Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Lewandowski

Vascular & Interventional Radiology Chicago, IL Medical Doctor

NPI 1689618761 CMS profile 75644

680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611

Open in the dashboard

General payments

$953,980

418 records reported · program years 2019–2025

Research payments

$15,550

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$8,560

3 holdings reported · through program year 2025

Research they led as principal investigator

$346,076 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Robert Lewandowski of Chicago, IL is reported in the CMS Open Payments database as having received $953,980 across 418 general payments and $15,550 in research payments paid to them. Separately, studies naming them as principal investigator received $346,076 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $8,560 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $335,617 101
2024 General $138,933 69
2024 Research $6,112 3
2023 General $109,452 67
2022 General $92,038 60
2021 General $127,969 42
2020 General $68,660 32
2019 General $81,309 47
2019 Research $9,438 1
2025 Ownership $4,200 1
2024 Ownership $4,350 1
2023 Ownership $10 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Lewandowski
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Robert Lewandowski were reported at $335,617. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Robert Lewandowski Vascular & Interventional Radiology median Middle half National median
2019 $81,309 $422 $125–$1,555 $163
2020 $68,660 $200 $68–$652 $114
2021 $127,969 $280 $99–$866 $132
2022 $92,038 $433 $137–$1,497 $149
2023 $109,452 $506 $152–$2,019 $160
2024 $138,933 $556 $175–$1,930 $164
2025 $335,617 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $318,315 114 payments
  2. Surefire Medical, Inc. $261,196 16 payments
  3. Boston Scientific Corporation $142,444 142 payments
  4. Biocompatibles, Inc. $62,243 17 payments
  5. ABK Biomedical USA, Inc. $31,163 15 payments
  6. Siemens Medical Solutions USA, Inc. $30,918 16 payments
  7. AstraZeneca Pharmaceuticals LP $27,101 19 payments
  8. Delcath Systems $21,585 12 payments
  9. Eisai Inc. $12,800 3 payments
  10. Varian Medical Systems, Inc. $12,347 6 payments
  11. Other $33,867 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $733,101 175 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $93,738 33 payments
  3. Travel and Lodging $84,752 95 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $28,080 2 payments
  5. Food and Beverage $11,531 111 payments
  6. Education $1,978 1 payment
  7. Grant $800 1 payment
Products named General payments · program years 2019–2025
  1. TRINAV INFUSION SYSTEM $261,196 16 payments
  2. THERASPHERE - BIO $62,009 13 payments
  3. TheraSphere Y90 Glass Microspheres 10 GBq $41,517 38 payments
  4. Eye90 microspheres $30,563 14 payments
  5. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $26,655 18 payments
  6. Hepzato Kit $21,585 12 payments
  7. IMFINZI $17,561 11 payments
  8. General - Therapies $17,063 8 payments
  9. Lenvima $12,800 3 payments
  10. General - Interventional Oncology $8,142 4 payments
  11. Other $51,184 106 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $9,438 1 payment
  2. ABK Biomedical USA, Inc. $6,112 3 payments

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$99,986

Medicare's payments for the services billed

Medicare patients

159

Average age 71

Services billed

1,102

64 women, 95 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 55%
Diabetes 52%
Ischemic heart disease 48%
Arthritis 47%
Heart failure 41%
Cancer 31%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Lenvima
  • Eisai Inc. $12,000
$12,000 — —
Hepzato Kit
  • Delcath Systems $3,937
$3,937 — —
IMFINZI
  • AstraZeneca Pharmaceuticals LP $2,160
$2,160 — —
TECENTRIQ
  • Genentech USA, Inc. $1,995
$1,995 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

422 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record